Skip to main content
MBBS DegreeFaculty of Faculty of Medical, Health & Clinical SciencesMedicine & Surgery

MED 502: Clinical Oncology, Hematologic Malignancies & Palliative Care (500 Level)

Oncological principles, tumor staging (TNM), systemic antineoplastic regimens, acute/chronic leukemias, lymphomas, multiple myeloma, and end-of-life palliative care.

Instructor
Created by PAMCET Learning Team
advanced1 weekEnglish

Course Overview

Oncological principles, tumor staging (TNM), systemic antineoplastic regimens, acute/chronic leukemias, lymphomas, multiple myeloma, and end-of-life palliative care. Curriculum Structure & Core Modules: • 1. Principles of Clinical Oncology: Carcinogenesis, Biomarkers, TNM...

What You'll Learn

  • Classify solid tumors by TNM staging and formulate multidisciplinary tumor board treatment recommendations.
  • Recognize and immediately manage oncological emergencies: neutropenic fever, SVC syndrome, and cord compression.
  • Diagnose and manage acute lymphoblastic/myeloblastic leukemias, chronic leukemias, and Hodgkin/Non-Hodgkin lymphomas.
  • Evaluate clinical presentation and laboratory staging (CRAB criteria) in multiple myeloma.
  • Apply the WHO pain ladder and manage end-of-life symptoms (dyspnea, nausea, delirium) in palliative care patients.

Requirements

  • MED 401 credit
  • PTH 401 credit

Degree Programme Curriculum Context

This course is a curriculum unit of the Bachelor of Medicine, Bachelor of Surgery (MBBS) degree framework in Nigeria.

Earn Your Certificate

Showcase your skills with a certificate! Complete the course, submit your project, and earn your certificate. Here's a sample of what you'll receive to show off your accomplishments.

course-certificate
Lecture Board & Syllabus

Course Curriculum

Browse complete theoretical foundations, worked calculations, laboratory protocols, and board assessment questions under each topic.

Launch Course Reader →
8 Chapters
•
16 Lecture
•
0s
Subtopic 1Document LectureOpen Access~27 min read

Principles of Clinical Oncology: Carcinogenesis, Biomarkers, TNM Staging & Multidisciplinary Care: Structural Principles & Pathophysiological Derangements

MED 502 • 500L • Internal Medicine • Chapter 1 • Lecture 1 Principles of Clinical Oncology: Carcinogenesis, Biomarkers, TNM Staging & Multidisciplinary Care: Structural Principles, Functional Architecture & Pathophysiological Derangements Curriculum Reference: MED 502: Clinical Oncology, Hematologic Malignancies & Palliative Care (500 Level) • Internal Medicine & S...

Module 1 • Subtopic 1•22,875 characters of authentic academic content
Subtopic 2Document Lecture

Principles of Clinical Oncology: Carcinogenesis, Biomarkers, TNM Staging & Multidisciplinary Care: Clinical Semiology, Differential Diagnosis & Evidence-Based Management

MED 502 • 500L • Internal Medicine • Chapter 1 • Lecture 2 Principles of Clinical Oncology: Carcinogenesis, Biomarkers, TNM Staging & Multidisciplinary Care: Clinical Semiology, Differential Diagnosis & Evidence-Based Bedside Management Curriculum Reference: MED 502: Clinical Oncology, Hematologic Malignancies & Palliative Care (500 Level) • MDCN Professional MBBS...

Module 1 • Subtopic 2
Formative Assessment10 Points • 15 Mins

Principles of Clinical Oncology: Carcinogenesis, Biomarkers, TNM Staging & Multidisciplinary Care: Formative Clinical Case Assessment

Assessment Protocol:10 Total Points•70% Passing Threshold•15 Mins Time Limit•Bloom's Taxonomy: Analyze & Evaluate

Authentic clinical vignette self-assessment evaluating semiology, diagnostic decision-making, and therapeutics for Principles of Clinical Oncology: Carcinogenesis, Biomarkers, TNM Staging & Multidisciplinary Care.

Module 1 • Formative Assessment
Subtopic 1Document LectureOpen Access~27 min read

Antineoplastic Therapies: Cytotoxics, Targeted Tyrosine Kinase Inhibitors & Immune Checkpoint Inhibitors: Structural Principles & Pathophysiological Derangements

MED 502 • 500L • Internal Medicine • Chapter 2 • Lecture 1 Antineoplastic Therapies: Cytotoxics, Targeted Tyrosine Kinase Inhibitors & Immune Checkpoint Inhibitors: Structural Principles, Functional Architecture & Pathophysiological Derangements Curriculum Reference: MED 502: Clinical Oncology, Hematologic Malignancies & Palliative Care (500 Level) • Internal Medic...

Module 2 • Subtopic 1•22,235 characters of authentic academic content
Subtopic 2Document Lecture

Antineoplastic Therapies: Cytotoxics, Targeted Tyrosine Kinase Inhibitors & Immune Checkpoint Inhibitors: Clinical Semiology, Differential Diagnosis & Evidence-Based Management

MED 502 • 500L • Internal Medicine • Chapter 2 • Lecture 2 Antineoplastic Therapies: Cytotoxics, Targeted Tyrosine Kinase Inhibitors & Immune Checkpoint Inhibitors: Clinical Semiology, Differential Diagnosis & Evidence-Based Bedside Management Curriculum Reference: MED 502: Clinical Oncology, Hematologic Malignancies & Palliative Care (500 Level) • MDCN Professiona...

Module 2 • Subtopic 2
Formative Assessment10 Points • 15 Mins

Antineoplastic Therapies: Cytotoxics, Targeted Tyrosine Kinase Inhibitors & Immune Checkpoint Inhibitors: Formative Clinical Case Assessment

Assessment Protocol:10 Total Points•70% Passing Threshold•15 Mins Time Limit•Bloom's Taxonomy: Analyze & Evaluate

Authentic clinical vignette self-assessment evaluating semiology, diagnostic decision-making, and therapeutics for Antineoplastic Therapies: Cytotoxics, Targeted Tyrosine Kinase Inhibitors & Immune Checkpoint Inhibitors.

Module 2 • Formative Assessment
Subtopic 1Document LectureOpen Access~27 min read

Oncological Emergencies: Febrile Neutropenia, Superior Vena Cava Obstruction, Cord Compression & Hypercalcemia: Structural Principles & Pathophysiological Derangements

MED 502 • 500L • Internal Medicine • Chapter 3 • Lecture 1 Oncological Emergencies: Febrile Neutropenia, Superior Vena Cava Obstruction, Cord Compression & Hypercalcemia: Structural Principles, Functional Architecture & Pathophysiological Derangements Curriculum Reference: MED 502: Clinical Oncology, Hematologic Malignancies & Palliative Care (500 Level) • Internal...

Module 3 • Subtopic 1•22,922 characters of authentic academic content
Subtopic 2Document Lecture

Oncological Emergencies: Febrile Neutropenia, Superior Vena Cava Obstruction, Cord Compression & Hypercalcemia: Clinical Semiology, Differential Diagnosis & Evidence-Based Management

MED 502 • 500L • Internal Medicine • Chapter 3 • Lecture 2 Oncological Emergencies: Febrile Neutropenia, Superior Vena Cava Obstruction, Cord Compression & Hypercalcemia: Clinical Semiology, Differential Diagnosis & Evidence-Based Bedside Management Curriculum Reference: MED 502: Clinical Oncology, Hematologic Malignancies & Palliative Care (500 Level) • MDCN Profe...

Module 3 • Subtopic 2
Formative Assessment10 Points • 15 Mins

Oncological Emergencies: Febrile Neutropenia, Superior Vena Cava Obstruction, Cord Compression & Hypercalcemia: Formative Clinical Case Assessment

Assessment Protocol:10 Total Points•70% Passing Threshold•15 Mins Time Limit•Bloom's Taxonomy: Analyze & Evaluate

Authentic clinical vignette self-assessment evaluating semiology, diagnostic decision-making, and therapeutics for Oncological Emergencies: Febrile Neutropenia, Superior Vena Cava Obstruction, Cord Compression & Hypercalcemia.

Module 3 • Formative Assessment
Subtopic 1Document LectureOpen Access~27 min read

Tumor Lysis Syndrome: Risk Stratification, Hydration, Rasburicase & Allopurinol Prophylaxis: Structural Principles & Pathophysiological Derangements

MED 502 • 500L • Internal Medicine • Chapter 4 • Lecture 1 Tumor Lysis Syndrome: Risk Stratification, Hydration, Rasburicase & Allopurinol Prophylaxis: Structural Principles, Functional Architecture & Pathophysiological Derangements Curriculum Reference: MED 502: Clinical Oncology, Hematologic Malignancies & Palliative Care (500 Level) • Internal Medicine & Systemi...

Module 4 • Subtopic 1•22,783 characters of authentic academic content
Subtopic 2Document Lecture

Tumor Lysis Syndrome: Risk Stratification, Hydration, Rasburicase & Allopurinol Prophylaxis: Clinical Semiology, Differential Diagnosis & Evidence-Based Management

MED 502 • 500L • Internal Medicine • Chapter 4 • Lecture 2 Tumor Lysis Syndrome: Risk Stratification, Hydration, Rasburicase & Allopurinol Prophylaxis: Clinical Semiology, Differential Diagnosis & Evidence-Based Bedside Management Curriculum Reference: MED 502: Clinical Oncology, Hematologic Malignancies & Palliative Care (500 Level) • MDCN Professional MBBS Exam /...

Module 4 • Subtopic 2
Formative Assessment10 Points • 15 Mins

Tumor Lysis Syndrome: Risk Stratification, Hydration, Rasburicase & Allopurinol Prophylaxis: Formative Clinical Case Assessment

Assessment Protocol:10 Total Points•70% Passing Threshold•15 Mins Time Limit•Bloom's Taxonomy: Analyze & Evaluate

Authentic clinical vignette self-assessment evaluating semiology, diagnostic decision-making, and therapeutics for Tumor Lysis Syndrome: Risk Stratification, Hydration, Rasburicase & Allopurinol Prophylaxis.

Module 4 • Formative Assessment
Subtopic 1Document LectureOpen Access~27 min read

Hematologic Malignancies I: Acute Myeloid & Lymphoblastic Leukemias, FAB/WHO Classifications & Remission: Structural Principles & Pathophysiological Derangements

MED 502 • 500L • Internal Medicine • Chapter 5 • Lecture 1 Hematologic Malignancies I: Acute Myeloid & Lymphoblastic Leukemias, FAB/WHO Classifications & Remission: Structural Principles, Functional Architecture & Pathophysiological Derangements Curriculum Reference: MED 502: Clinical Oncology, Hematologic Malignancies & Palliative Care (500 Level) • Internal M...

Module 5 • Subtopic 1•22,914 characters of authentic academic content
Subtopic 2Document Lecture

Hematologic Malignancies I: Acute Myeloid & Lymphoblastic Leukemias, FAB/WHO Classifications & Remission: Clinical Semiology, Differential Diagnosis & Evidence-Based Management

MED 502 • 500L • Internal Medicine • Chapter 5 • Lecture 2 Hematologic Malignancies I: Acute Myeloid & Lymphoblastic Leukemias, FAB/WHO Classifications & Remission: Clinical Semiology, Differential Diagnosis & Evidence-Based Bedside Management Curriculum Reference: MED 502: Clinical Oncology, Hematologic Malignancies & Palliative Care (500 Level) • MDCN Profess...

Module 5 • Subtopic 2
Formative Assessment10 Points • 15 Mins

Hematologic Malignancies I: Acute Myeloid & Lymphoblastic Leukemias, FAB/WHO Classifications & Remission: Formative Clinical Case Assessment

Assessment Protocol:10 Total Points•70% Passing Threshold•15 Mins Time Limit•Bloom's Taxonomy: Analyze & Evaluate

Authentic clinical vignette self-assessment evaluating semiology, diagnostic decision-making, and therapeutics for Hematologic Malignancies I: Acute Myeloid & Lymphoblastic Leukemias, FAB/WHO Classifications & Remission.

Module 5 • Formative Assessment
Subtopic 1Document LectureOpen Access~27 min read

Hematologic Malignancies II: Chronic Myeloid Leukemia (BCR-ABL, Imatinib), CLL & Hodgkin/Non-Hodgkin Lymphoma: Structural Principles & Pathophysiological Derangements

MED 502 • 500L • Internal Medicine • Chapter 6 • Lecture 1 Hematologic Malignancies II: Chronic Myeloid Leukemia (BCR-ABL, Imatinib), CLL & Hodgkin/Non-Hodgkin Lymphoma: Structural Principles, Functional Architecture & Pathophysiological Derangements Curriculum Reference: MED 502: Clinical Oncology, Hematologic Malignancies & Palliative Care (500 Level) • Internal...

Module 6 • Subtopic 1•22,921 characters of authentic academic content
Subtopic 2Document Lecture

Hematologic Malignancies II: Chronic Myeloid Leukemia (BCR-ABL, Imatinib), CLL & Hodgkin/Non-Hodgkin Lymphoma: Clinical Semiology, Differential Diagnosis & Evidence-Based Management

MED 502 • 500L • Internal Medicine • Chapter 6 • Lecture 2 Hematologic Malignancies II: Chronic Myeloid Leukemia (BCR-ABL, Imatinib), CLL & Hodgkin/Non-Hodgkin Lymphoma: Clinical Semiology, Differential Diagnosis & Evidence-Based Bedside Management Curriculum Reference: MED 502: Clinical Oncology, Hematologic Malignancies & Palliative Care (500 Level) • MDCN Profes...

Module 6 • Subtopic 2
Formative Assessment10 Points • 15 Mins

Hematologic Malignancies II: Chronic Myeloid Leukemia (BCR-ABL, Imatinib), CLL & Hodgkin/Non-Hodgkin Lymphoma: Formative Clinical Case Assessment

Assessment Protocol:10 Total Points•70% Passing Threshold•15 Mins Time Limit•Bloom's Taxonomy: Analyze & Evaluate

Authentic clinical vignette self-assessment evaluating semiology, diagnostic decision-making, and therapeutics for Hematologic Malignancies II: Chronic Myeloid Leukemia (BCR-ABL, Imatinib), CLL & Hodgkin/Non-Hodgkin Lymphoma.

Module 6 • Formative Assessment
Subtopic 1Document LectureOpen Access~27 min read

Multiple Myeloma & Plasma Cell Disorders: CRAB Criteria, Serum Protein Electrophoresis & Autologous SCT: Structural Principles & Pathophysiological Derangements

MED 502 • 500L • Internal Medicine • Chapter 7 • Lecture 1 Multiple Myeloma & Plasma Cell Disorders: CRAB Criteria, Serum Protein Electrophoresis & Autologous SCT: Structural Principles, Functional Architecture & Pathophysiological Derangements Curriculum Reference: MED 502: Clinical Oncology, Hematologic Malignancies & Palliative Care (500 Level) • Internal Me...

Module 7 • Subtopic 1•22,333 characters of authentic academic content
Subtopic 2Document Lecture

Multiple Myeloma & Plasma Cell Disorders: CRAB Criteria, Serum Protein Electrophoresis & Autologous SCT: Clinical Semiology, Differential Diagnosis & Evidence-Based Management

MED 502 • 500L • Internal Medicine • Chapter 7 • Lecture 2 Multiple Myeloma & Plasma Cell Disorders: CRAB Criteria, Serum Protein Electrophoresis & Autologous SCT: Clinical Semiology, Differential Diagnosis & Evidence-Based Bedside Management Curriculum Reference: MED 502: Clinical Oncology, Hematologic Malignancies & Palliative Care (500 Level) • MDCN Professi...

Module 7 • Subtopic 2
Formative Assessment10 Points • 15 Mins

Multiple Myeloma & Plasma Cell Disorders: CRAB Criteria, Serum Protein Electrophoresis & Autologous SCT: Formative Clinical Case Assessment

Assessment Protocol:10 Total Points•70% Passing Threshold•15 Mins Time Limit•Bloom's Taxonomy: Analyze & Evaluate

Authentic clinical vignette self-assessment evaluating semiology, diagnostic decision-making, and therapeutics for Multiple Myeloma & Plasma Cell Disorders: CRAB Criteria, Serum Protein Electrophoresis & Autologous SCT.

Module 7 • Formative Assessment
Subtopic 1Document LectureOpen Access~28 min read

Palliative & End-of-Life Care: Symptom Control, Opioid Titration, Advance Care Directives & Bereavement: Structural Principles & Pathophysiological Derangements

MED 502 • 500L • Internal Medicine • Chapter 8 • Lecture 1 Palliative & End-of-Life Care: Symptom Control, Opioid Titration, Advance Care Directives & Bereavement: Structural Principles, Functional Architecture & Pathophysiological Derangements Curriculum Reference: MED 502: Clinical Oncology, Hematologic Malignancies & Palliative Care (500 Level) • Internal Me...

Module 8 • Subtopic 1•22,956 characters of authentic academic content
Subtopic 2Document Lecture

Palliative & End-of-Life Care: Symptom Control, Opioid Titration, Advance Care Directives & Bereavement: Clinical Semiology, Differential Diagnosis & Evidence-Based Management

MED 502 • 500L • Internal Medicine • Chapter 8 • Lecture 2 Palliative & End-of-Life Care: Symptom Control, Opioid Titration, Advance Care Directives & Bereavement: Clinical Semiology, Differential Diagnosis & Evidence-Based Bedside Management Curriculum Reference: MED 502: Clinical Oncology, Hematologic Malignancies & Palliative Care (500 Level) • MDCN Professi...

Module 8 • Subtopic 2
Formative Assessment10 Points • 15 Mins

Palliative & End-of-Life Care: Symptom Control, Opioid Titration, Advance Care Directives & Bereavement: Formative Clinical Case Assessment

Assessment Protocol:10 Total Points•70% Passing Threshold•15 Mins Time Limit•Bloom's Taxonomy: Analyze & Evaluate

Authentic clinical vignette self-assessment evaluating semiology, diagnostic decision-making, and therapeutics for Palliative & End-of-Life Care: Symptom Control, Opioid Titration, Advance Care Directives & Bereavement.

Module 8 • Formative Assessment

Instructor

PAMCET Learning Team

PAMCET Learning Team

Institutional Course Curation · PAMCET

The PAMCET Learning Team is the institutional curriculum and content group behind course publishing on this platform. PAMCET (Professional and Academic Management Centre for Education and Training) is operated by Digitpen Hub Ltd, a company registered in Lagos, Nigeria. Courses credited to the PAMCET Learning Team are structured, organized, and published centrally by the platform rather than authored by a single named individual instructor — each course's syllabus, learning outcomes, and content are reviewed before publication under this institutional account. For questions about a specific course or to report a content issue, please use the platform's Help & Support or Contact Us pages.

Qualifications:

PAMCET Learning Team — Institutional Course Curation, Digitpen Hub Ltd

My Skills:

  • Curriculum Curation
  • Course Content Review
  • Learning Outcome Design
  • Course Publishing & Quality Assurance
  • Platform Content Operations

Reviews

No reviews available
MED 502: Clinical Oncology, Hematologic Malignancies & Palliative Care (500 Level)
Free$24.99100% Off
Certificate available separately for $7 after completion

Course Includes

8 Chapters
16 Lectures
1 week
Skill Level advanced
Taught in English
Lifetime Access
Certification of Completion
Category: University - Medicine & Surgery
Share On

Download Syllabus & Study Guide

Receive the full lecture syllabus, reading list, and milestone schedule for MED 502: Clinical Oncology, Hematologic Malignancies & Palliative Care (500 Level).

By submitting, you agree to receive educational updates. You can unsubscribe anytime. Read our Privacy Policy.